Richard Steinhart
Chief Financial Officer
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | BioXcel Therapeutics, Inc. (BTAI) | SVP and Chief Financial Officer | $409,872 | $998,216 |
| 2019 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | $285,600 | $403,997 |
Earnings-call appearances
-
BioXcel Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-14
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-09
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q4 FY2023 Earnings Call2024-03-12
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-14
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-14
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-08
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q4 FY2022 Earnings Call2023-03-09
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-10
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-09
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-09
BioXcel Therapeutics, Inc. (BTAI)